Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Two Calculated Risks Possibly Worth Taking
- David White submits: Many people are thinking there will be an Obama rally in January, in part due to his popularity and in part due to the stimulus package that he and the Congress are proposing. Then too there are the recent actions of the Fed – both lowering interest...
- External links 2008-12-28
- Two Near-Term Biotech Plays
- David White submits: The news wire yesterday (December 30, 2008) reported that two drug companies have been granted priority review status for their new submittals: Northfield Laboratories NFLD and Savient Pharmaceticals SVNT. Naturally both of these stocks shot up yesterday. However, it will take time for the news to filter...
- External links 2008-12-31
- Hemispherx Biopharma: Hot and Likely to Get Hotter
- David White submits: Hemispherx Biopharma HEB put out a press release. They announced an invitation, funded entirely by the government of Italy, to present HEB's technology platform for influenza control, at the upcoming 'International Conference on Biotechnologies and Finance' in Rome on July 4-5, 2009. Hemispherx has a broad-based...
- External links 2009-06-03
- Buy Hemispherix Before Ampligen's FDA Approval
- David White submits: Hemispherix Biopharma HEB is awaiting news from the FDA on its NDA application for Ampligen as a treatment for Chronic Fatigue Syndrome. The stock has soared from about $0.38 in March to a high of $4.54. Ampligen has received rave reviews for its efficacy as a flu...
- External links 2009-06-24
- HEB: Pressure Mounting on FDA to Approve Ampligen for Chronic Fatigue
- David White submits: Today AP reported that Andy Burnham, the British Health Minister, said the UK could have up to 100,000 new cases of swine flu per day by the end of August. Currently we have seen only about 100,000 reported cases worldwide. If the cries of Andy Burnham are...
- External links 2009-07-14
Additional Resources
- Who Is David Allen?
- With his popular seminar lectures and cult-like following, productivity expert David Allen has become an influential force in the Information Age workplace. Why He Matters Now: Since publishing his best-selling book Getting Things Done: The Art of Stress-Free Productivity in 2001, David Allen has...
- Articles 2007-03-12
- How Pharma's CEO Pay Packages Measure Up
- Since I've just spend close to a half-hour flipping through Big Pharma proxy filings, I figured I'd take just a little longer and put together a quick table of the best-paid chief executives in pharma and biotech. Enjoy. The following data is all taken from 2007 proxy...
- Blog posts 2008-04-24
- Roche Is Considerably Worse Off Without Genentech
- Mike Huckman submits: While much to my chagrin Genentech DNA isn't matching Roche's (RHHBY.PK) aggressive media strategy in the ongoing takeover battle, during parts of the biotech company's presentation to analysts and investors today, at least two executives pulled no punches. David Ebersman put up a slide titled,...
- External links 2009-03-02
- << Previous
- page 1 of 1
- Next >>
